A computational tool may help pharmaceutical companies expand their ability to investigate the safety of drugs.

GSK’s ViiV, armed with long-term Dovato data, eyes ‘tipping point’ for 2-drug HIV regimen aliu Mon, 10/05/2020 – […]

FiercePharmaPolitics—Latest need-to-know about President Trump’s COVID-19 case esagonowsky Mon, 10/05/2020 – 09:51

Novartis offloads 2 Spanish finished-dose facilities to Swiss contract manufacturer kblankenship Mon, 10/05/2020 – 10:24

Bristol Myers Squibb snags new Opdivo-Yervoy nod but chalks up failure in melanoma aliu Mon, 10/05/2020 – 11:19

Teva back on the hook for $235M to GSK for heart drug infringement esagonowsky Mon, 10/05/2020 – 11:22

An international team led by current and former McMaster University researchers has developed an artificial lung to support […]

One feature of the COVID-19 virus that makes it so difficult to contain is that it can be […]

Before the first commercial automated insulin delivery system became accessible in the UK last year, technologically minded patients […]

What you need to knowOral liquid formulations of common medicines are often tolerated by children who cannot swallow […]